LEADER 00800nam0-22003131i-450-
001 990000986590403321
010   $a0-330-26324-2
035   $a000098659
035   $aFED01000098659
035   $a(Aleph)000098659FED01
035   $a000098659
100   $a20000920d1981----km-y0itay50------ba
101 0 $aeng
200 1 $aDisturbing the Universe$fFreeeman Dyson
210   $aLondon [etc.]$cPan Books$d1981
610 0 $aAstronomia
610 0 $aAstrofisica
610 0 $aCosmologia
676   $a520
676   $a523
700  1$aDyson,$bFreeman J.$f<1923- >$040445
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990000986590403321
952   $a19-091$b11784$fFI1
959   $aFI1
996   $aDisturbing the Universe$9353757
997   $aUNINA
DB    $aING01

LEADER 01542nam  2200337   450 
001 9910729794203321
005 20230729195031.0
035   $a(CKB)4960000000468902
035   $a(NjHacI)994960000000468902
035   $a(EXLCZ)994960000000468902
100   $a20230729d2023      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBiomarkers in Neurodegenerative Diseases 2.0 /$fArnab Ghosh
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2023.
215   $a1 online resource (206 pages)
311   $a3-0365-5732-6 
330   $aThis book follows up on the previous volume focusing on the different biomarkers for neurodegenerative diseases. It includes original research works and review articles focusing on an improved understanding of disease mechanisms. It also aims to identify aspects of early therapeutic intervention for enhanced disease management. Some critical approaches include studies involving human tissue samples, mouse disease models, and different imaging techniques. These studies present the essential information necessary to address such pathological conditions in the future.
606   $aNeurosciences
615  0$aNeurosciences.
676   $a616.8
700   $aGhosh$b Arnab$01316713
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910729794203321
996   $aBiomarkers in Neurodegenerative Diseases 2.0$93416957
997   $aUNINA